Here's Why Barclays Is Bullish On Intercept Pharma

By: via Benzinga
Intercept Pharmaceuticals Inc’s (NASDAQ: ICPT) liver drug Ocaliva has been granted accelerated approval by the FDA. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.